Metronomia
Private Company
Total funding raised: $2.8M
Overview
Metronomia is a Germany-based, service-oriented CRO founded in 2020, specializing in biostatistics and clinical data management. With a team of more than 150 experts, the company serves global pharmaceutical and biotech clients, boasting a high repeat business rate exceeding 92% and a portfolio of over 720 projects. Its business model is built on providing flexible, high-quality statistical and data management services, positioning it as a trusted partner in clinical research rather than a developer of its own therapeutics or AI platforms.
Technology Platform
Service-oriented expertise in biostatistics and clinical data management utilizing industry-standard software (e.g., SAS, R, EDC systems) and advanced statistical methodologies.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes in the crowded CRO market, differentiated by a focused offering on biometrics and a mid-size, high-touch service model. Key competitors range from large global CROs (IQVIA, Parexel, PPD) to numerous small boutique biostatistics firms. Its >92% repeat business suggests strong competitive retention.